Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tapering Heart Failure Medication in Patients With Heart Failure With Recovered Ejection Fraction; Open Label Prospective Random Trial

NCT06724653 is registered in ClinicalTrials.gov with Chungnam National University Hospital as lead sponsor.

NCT NCT06724653
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06724653 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tapering Heart Failure Medication in Patients With Heart Failure With Recovered Ejection Fraction; Open Label Prospective Random Trial
Lead sponsor
Chungnam National University Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
March 6, 2025
Completion date
November 26, 2027
Enrollment
150 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

ejection fraction, heart failure, recovery of function